Follow #AMA on social media
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Compounded medications are not FDA-approved, are not generics, and do not undergo the same FDA premarket review for safety, effectiveness, quality, labeling, and manufacturing as brand products
Conclusion: In patients with T2DM, patients with treatment of GLP-1 RAs resulted in lower risks of osteoporosis than those without treatment of GLP-1 RAs
Progress varies based on individual factors, lifestyle habits, and program participation
This guide covers every supplement worth considering when using GLP-1 medications